Doctors Praise Moderna and Merck Cancer Vaccine

Cancer doctors see fresh hope in the fight against deadly skin cancer. Six top specialists say a new treatment from Moderna and Merck marks a major leap forward for patients.

The treatment combines an mRNA vaccine with a proven cancer drug. It targets melanoma in patients who already had surgery. The specialists note that the shot cuts the risk of cancer returning. Wall Street had a muted reaction to the update, but medical experts focus on patient survival.

This progress shows how mRNA science expands past common viruses. Cancer care now moves toward custom treatments that teach the body to defend itself.

Source: CNBC